Federal award
ORTHO-CLINICAL DIAGNOSTICS, INC
FA446018F0004
Contract
Obligated and Ceiling
- Obligated (net)
- $315,031.62
- Ceiling (potential value, not spending)
- $315,031.62
- Current value
- $315,031.62
- Gross positive obligations
- $319,066.08
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ORTHO-CLINICAL DIAGNOSTICS, INC · JG5JF2JQJ121
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- JOHNSON & JOHNSON HEALTHCARE · LKV3QN1ND7D1
- Awarding agency
- Department of War · sub-agency 5700 · office FA4460
- Funding agency
- Department of War · sub-agency 5700
- Product or service (PSC)
- 6640 · LABORATORY EQUIPMENT AND SUPPLIES
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- FA446018F0004
- Parent vehicle (IDV PIID)
- V797P7126A
- Award type code
- C
- Actions
- 10 · Oct 3, 2017 to Mar 25, 2020
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History10
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 25, 2020 | FY2020 | P00009 | C | −$4,034.46 | — |
| Dec 27, 2019 | FY2020 | P00008 | B | $0.00 | — |
| Oct 1, 2019 | FY2020 | P00007 | C | $60,000.00 | — |
| Sep 10, 2019 | FY2019 | P00006 | G | $0.00 | — |
| Oct 1, 2018 | FY2019 | P00004 | C | $129,533.04 | — |
| Oct 1, 2018 | FY2019 | P00005 | M | $0.00 | — |
| May 11, 2018 | FY2018 | P00003 | M | $0.00 | — |
| May 9, 2018 | FY2018 | P00002 | M | $0.00 | — |
| Mar 16, 2018 | FY2018 | P00001 | M | $0.00 | — |
| Oct 3, 2017 | FY2018 | 0 | — | $129,533.04 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.
